Healthcare Industry News Weekly Wrap-Up: March 28, 2024
// Biotech and Pharma Therapeutics Following Boehringer’s lead, AstraZeneca caps monthly out-of-pocket inhaler costs at $35 in the US March 18, 2024 / AstraZeneca / Symbicort / Inhaled Medicines / Asthma AstraZeneca on Monday revealed it’s expanding a savings program...